Obama to Back Brain Mapping

A new project to map the activity of the human brain could receive more than $3 billion dollars in federal funds in President Obama’s upcoming budget proposal.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, THEBRAINA large-scale effort to understand the human brain and build a comprehensive map of its activity is set to launch with the help of billions of dollars in federal funds. According to The New York Times, President Obama will outline the plan to fund the decade-long Brain Activity Map project in his federal budget proposal, which the White House is slated to release next month. Scientists involved in planning the project hope that it will have the same catalytic effect on brain research as the $3.8 billion Human Genome Project had on genetics, and that it will spur the development of new therapies for various brain diseases.

The White House Office for Science and Technology Policy did not comment on the speculation, but several scientists and institutions, including the National Institutes of Health (NIH), confirmed their involvement in planning the project. Indeed, Obama may have been teasing the new project during his recent State of the Union address, when he cited brain research as the kind of science in which government should invest. And NIH director Francis Collins may have accidently confirmed as much immediately after the speech when he tweeted, “Obama mentions #NIH Brain Activity Map in #SOTU.”

Harvard molecular biologist George Church, who is part of the planning team, told the Times that the scientists behind the initiative hope to get federal backing to the tune of more than $3 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies